Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-13-004774

Options or other derivatives

  • Director acquired 721,068 shares (other)

From the SEC's structured data for this filing

Trades in this filing

SETH SANDESH · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2013-07-25 Other acquisition : show line 1 in the form Common Stock Purchase Warrant +721,068 $0.01 $7,211 178,350 I
Loading xslF345X03/f4072513seth_actinium.xml…